Avecho Biotechnology (AVE) Short Interest
Avecho Biotechnology (ASX:AVE) had 0.00% of shares reported as short positions as of 10 Feb 2025, representing 29,568 shares. Avecho Biotechnology operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Avecho Biotechnology
Avecho Biotechnology is an Australian innovation-led biotechnology company focused on developing and commercializing human health, animal health, and personal care products. They utilize their proprietary drug delivery system called Tocopheryl Phosphate Mixture (TPM) to enhance the solubility and adsorption of drugs and nutrients. Avecho aims to create new market opportunities for healthcare leaders by differentiating their products.
Short position
Avecho Biotechnology (ASX:AVE) has 0.00% of its shares on issue reported as short positions as of 10 Feb 2025, or about 29,568 shares. Over the past 30 days that figure has fallen 0.12 percentage points, and over 90 days it has fallen 0.12 percentage points. Its highest recorded short interest was 0.55% in November 2010. AVE is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Weekly context: The 10 most shorted ASX stocks — Week 35, 2026.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4AVE intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
Company
AI-generated research profile of Avecho Biotechnology
Latest AVE news
All news- What Could Shape Avecho (ASX:AVE) as Its Next Clinical Phase Develops?
kalkine
- We're Hopeful That Avecho Biotechnology (ASX:AVE) Will Use Its Cash Wisely - simplywall.st
googlenews
- Notification regarding unquoted securities - AVE
asx
- Appendix 4D and Half-year Financial Report
asx
- Avecho strengthens BD capability with senior appointment
asx
About
More Pharmaceuticals, Biotechnology & Life Sciences Stocks
Other shorted stocks in this sector
Be the first to discuss AVE
Start a research thread or post the first pulse update